Health Policy News
Stanford's Michelle Mello and her colleague Lawrence O. Gostin at Georgetown University analyze the strains that public health emergency powers underwent during the pandemic, then propose reforms to modernize public health law. Mello then discusses the issue with Health Affairs' Editor-in-Chief Alan Weil for his "Health Podyssey" podcast.
In this JAMA Health Forum commentary, SHP's Michelle Mello and colleagues argue that the $1.7 trillion omnibus bill that Congress passed in December 2022 responds to several urgent public health needs, yet only narrowly addresses some of the critical determinants of pandemic preparedness.
A recently released report from an expert committee of the National Academies of Sciences, Engineering, and Medicine — including Stanford Law School and Department of Health Policy professor Michelle Mello and former Rosenkranz Prize winner Ami Bhatt — focuses on how wastewater monitoring has become a critical tool in the fight against infectious diseases.
A new paper by Michelle Mello and colleagues at Stanford and Yale outlines the "fair inclusion score," which ranks pharmaceutical companies on their inclusion of racial and ethnic minoritized groups, women, and the elderly in clinical trials.
Michelle Mello — a professor of heath policy and law — attended the Sept. 13 gathering at the White House to celebrate the passing of the Inflation Reduction Act 2022. She was invited for her contributions on Medicare price negotiation modeling for the landmark piece of legislation. In this Q&A, she discusses the bill's impact on health policy.
In this Q&A with Stephanie Ashe at Stanford Law, SHP's Michelle Mello — a professor of health policy and a professor of law — examines the guidance for health-care providers recently issued by the Biden Administration.
Michelle Mello writes that the overturning of Roe v. Wade — ending federal protection over a woman's right to an abortion — could also expose her personal health data in court.
Michelle Mello and Stanford colleagues win an annual award by the ABIM Foundation for a commentary that argued academics have an obligation to speak out against medical views that are contrary to science.
The COVID-19 pandemic has focused attention on the complex and sometimes conflicting relationship between individual rights and public health protection.
Two Stanford law, labor and health experts explain the legal and health implications of the Supreme Court ruling that struck down the Biden administration's COVID-19 vaccine mandate for large companies, while upholding another federal regulation calling on health-care workers in federally funded facilities to be vaccinated.
Litigation over mask mandates takes a bizarre turn after political leaders in eight states introduce bans on mask requirements. Some state bans apply only to mandates adopted by school districts; others are broader. In this JAMA Health Forum viewpoint, health law experts Michelle Mello and David Studdert look at the various lawsuits, court rulings — and possible solutions.
President Biden announced sweeping new mandates meant to push an estimated two-thirds of American workers to get the COVID-19 vaccine and stem the tide of the latest Delta wave of the pandemic. Health law expert Michelle Mello weighs in.
In this New England Journal of Medicine perspective, SHP's Michelle Mello writes that more than 1,000 lawsuits have challenged public health orders shuttering business, banning indoor worship, restricting travel and mandating masks. She argues that the outcome of these cases will have a lasting impact on our public health.
Stanford health law experts Michelle Mello and David Studdert discuss the ongoing pandemic, proof of vaccination “passports” at the state and federal levels, and a July 19 ruling that Indiana University could require that its students be vaccinated.
Michelle Mello writes in this San Francisco Chronicle commentary that her husband had a stroke a few days after getting his COVID vaccine. On the same day he checked into a hospital, their son was offered the vaccine. They listened to the doctors and determined the risk of COVID outweighed the potential risks from the vaccine.
Stanford’s Center for Open and Reproducible Science aims to make science – and research in general – more effective and accessible. “Stanford is absolutely the right place to have a center like CORES because we have such a strong tradition of data science," says SHP's Michelle Mello, a member of the CORES executive committee.
In its third major decision about the Affordable Care Act, the U.S. Supreme Court rejects efforts to undo the popular health care law.
Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in California
Michelle Mello evaluates the benefits and challenges of California's novel health equity focus in its reopening efforts and outlines recommendations for other U.S. states to address disparities in their reopening plans.
Now that a third COVID-19 vaccine has been given emergency-use authorization, Michelle Mello and colleagues ask whether individuals should be able to choose which vaccine they receive.
Stanford Law School health law experts Michelle Mello and David Studdert, also professors of medicine at Stanford Health Policy, share insights into the government’s response and offer hope that science —and unbiased scholarly research — can help curtail the rising toll of COVID-19.
The Uncertain Impact of Accelerating Science
The urgency of the coronavirus pandemic has led to enormous research efforts and some shortcuts. Michelle Mello, a professor of medicine and law, and David Magnus, a professor of medicine and biomedical ethnics, write in this Scientific American commentary that the scientific surge to understand COVID-19 is inspiring — but has led to some ethical dilemmas.
SHP's Jeremy Goldhaber-Fiebert, David Studdert and Michelle Mello write in this JAMA Health Forum Insight that school reopening efforts must account for characteristics of the communities within which schools are embedded.
Stanford Health Policy's Michelle Mello and Stanford medical student Yasmin Rafiei write in this New England Journal of Medicine perspective that most school reopening plans focus on screening for Covid-19 symptoms. Yet recent research indicates that symptom screening alone will not enable schools to contain Covid-19 outbreaks.
SHP's Michelle Mello writes in this commentary in JAMA Network that the attacks on and harassment of public health officials for taking steps to protect their communities from COVID-19 is extraordinary in its scope and nature, use of social media — and poses a danger to the ongoing pandemic response.